Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic's $538 Mil. Physio-Control Buy Adds External Defibrillator Line

This article was originally published in The Gray Sheet

Executive Summary

Medtronic plans to accelerate the development of a prescription home-use market for automated external defibrillators upon completion of its $538 mil. acquisition of Physio-Control.

You may also be interested in...

Medtronic Spins Off $450 Mil. Physio-Control Unit In Search Of Higher Growth

Medtronic's planned spinoff of its Physio-Control external defibrillator business could allow accelerated growth of both companies, according to the firm

FDA Officials Cite Reasons For Denying Application Reviews Over Data Integrity Breaches

Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts